01173nas a2200289   4500000000100000008004100001260000900042653002700051653001200078653002900090653003700119653003300156653001100189653002300200653002300223653001200246653001900258653000900277653000900286653002300295653002100318100002200339245006800361300000800429520043200437022001400869       1989                            d  c198910aAdjuvants, Immunologic10aAnimals10aAntibody-Producing Cells10aDose-Response Relationship, Drug10aDrug Evaluation, Preclinical10aFemale10aImmunity, Cellular10aLeprostatic Agents10aleprosy10aLethal Dose 5010aMale10aMice10aMice, Inbred C57BL10aMice, Inbred CBA1 aGoloshchapova E N00a[Immunocorrective properties of new antileprotic preparations].  a7-93 a<p>Antimycobacterial and immunotropic characteristics of new antileprosy drugs, made in this country, have been studied and compared with those of dapsone. Animal experiments have demonstrated a high immunostimulating activity of the new drugs; this calls for clinical trials of these agents, for they may improve the therapy efficacy, help prevent the disease recurrences, and cut down the length of treatment for leprosy.</p>  a0042-4609